CHC Healthcare Group (TPE:4164)

Market Cap	7.64B
Revenue (ttm)	3.95B
Net Income (ttm)	174.52M
Shares Out	184.65M
EPS (ttm)	1.09
PE Ratio	37.83
Forward PE	n/a
Dividend	1.51 (3.63%)
Ex-Dividend Date	Jul 10, 2024

Volume	266,081
Average Volume	844,093
Open	41.70
Previous Close	41.60
Day's Range	41.20 - 41.85
52-Week Range	35.50 - 60.40
Beta	0.37
RSI	41.01
Earnings Date	May 6, 2025

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally. The company is also involved in the sale, leasing, installing, and repairing of medical instruments. In addition, it engages in the sale of ophthalmic equipment; irradiation business; sale of drug and health supplements; consulting, elderly residence, and senior fitness services; Long-term care services; and leasing of veterinary medical instruments. CHC Healthcare Group was founded in 1977 a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1977
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2024, CHC Healthcare Group's revenue was 3.60 billion, a decrease of -7.13% compared to the previous year's 3.88 billion. Earnings were 168.38 million, a decrease of -59.80%.